Association of HLA-DRB1*15:02 and DRB5*01:02 allele with the susceptibility to systemic sclerosis in Thai patients

Rheumatology International

Volumn 33, Issue 8, 2013, Pages 2069-2077

  Louthrenoo, Worawit ^a   Kasitanon, Nuntana ^a   Wichainun, Ramjai ^a   Wangkaew, Suparaporn ^a   Sukitawut, Waraporn ^a   Ohnogi, Yuka ^b   Nakaue, Naoko ^b   Kuwata, Shoji ^c   Takeuchi, Fujio ^b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b UNIVERSITY OF TOKYO   (Japan)

^c TEIKYO UNIVERSITY CHIBA MEDICAL CENTER   (Japan)

Author keywords

Genetic; HLA; MHC class II; Polymorphism; Scleroderma; Systemic sclerosis

Indexed keywords

HLA DR15 ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB5 ANTIGEN; SCL 70 ANTIBODY;

ADULT; ALLELE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA FINGERPRINTING; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; LUNG FIBROSIS; MALE; MYOSITIS; PRIORITY JOURNAL; SCAR; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS; THAILAND;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DRB1 CHAINS; HLA-DRB5 CHAINS; HUMANS; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; THAILAND;

EID: 84880916411     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-013-2686-3     Document Type: Article

References (29)

1. Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989-2003
2. Agarwal SK, Tan FK, Arnett FC (2008) Genetics and genomic studies in scleroderma (systemic sclerosis). Rheum Dis Clin North Am 34:17-40
3. Agarwal SK, Reveille JD (2010) The genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol 22:133-138
4. Romano E, Manetti M, Guiducci S, Ceccarelli C, Allanore Y, Matucci-Cerinic M (2011) The genetics of systemic sclerosis: an update. Clin Exp Rheumatol 29:S75-S86
5. Takeuchi F, Nakano K, Yamada H, Hong GH, Nabeta H, Yoshida A et al (1994) Association of HLA-DR with progressive systemic sclerosis in Japanese. J Rheumatol 21:857-863
6. Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J et al (2001) Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 30:332-346
7. Arnett FC, Gourh P, Shete S, Ahn CW, Honey RE, Agarwal SK et al (2010) Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls. Ann Rheum Dis 69:822-827
8. Assassi S, Del Junco D, Sutter K, McNearney TA, Reveille JD, Karnavas A et al (2009) Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthr Rheum 61:1403-1411
9. Kuwana M, Inoko H, Kameda H, Nojima T, Sato S, Nakamura K et al (1999) Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis. Intern Med 38:336-344
10. Akimoto S, Abe M, Ishikawa O (2000) HLA-DRB1 and DQB1 genes in Japanese patients with systemic sclerosis. J Rheumatol 27:2940-2942
11. Kang SH, Park MH, Song EY, Kang SJ, Lee EB, Song YW et al (2001) Association of HLA class II genes with systemic sclerosis in Koreans. J Rheumatol 28:1577-1583
12. Joung CI, Jun JB, Chung WT, Song GG, Choe JY, Chang HK et al (2006) Association between the HLA-DRB1 gene and clinical features of systemic sclerosis in Korea. Scand J Rheumatol 35:39-43
13. Zhou X, Lee JE, Arnett FC, Xiong M, Park MY, Yoo YK et al (2009) HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans. Arthr Rheum 60:3807-3814
14. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
15. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-205
16. Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM et al (2004) Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatol (Oxford) 43:461-466
17. Badesch DB, Abman SH, Simonneau G, Rubin LJ, McLaughlin VV (2007) Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 131:1917-1928
18. Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Ohnogi Y et al (2011) Lack of CTGF*-945C/G Dimorphism in Thai Patients with Systemic Sclerosis. Open Rheumatol J 5:59-63
19. Haldane JB (1956) The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 20:309-311
20. Loubiere LS, Lambert NC, Madeleine MM, Porter AJ, Mullarkey ME, Pang JM et al (2005) HLA allelic variants encoding DR11 in diffuse and limited systemic sclerosis in Caucasian women. Rheumatol (Oxford) 44:318-322
21. Gladman DD, Kung TN, Siannis F, Pellett F, Farewell VT, Lee P (2005) HLA markers for susceptibility and expression in scleroderma. J Rheumatol 32:1481-1487
22. Simeon CP, Fonollosa V, Tolosa C, Palou E, Selva A, Solans R et al (2009) Association of HLA class II genes with systemic sclerosis in Spanish patients. J Rheumatol 36:2733-2736
23. Vlachoyiannopoulos PG, Dafni UG, Pakas I, Spyropoulou-Vlachou M, Stavropoulos-Giokas C, Moutsopoulos HM (2000) Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele. Ann Rheum Dis 59:359-367
24. Frezza D, Giambra V, Tolusso B, De Santis M, Bosello S, Vettori S et al (2007) Polymorphism of immunoglobulin enhancer element HS1,2A: allele*2 associates with systemic sclerosis. Comparison with HLA-DR and DQ allele frequency. Ann Rheum Dis 66:1210-1215
25. Geirsson AJ, Steinsson K, Guthmundsson S, Sigurthsson V (1994) Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 53:502-505
26. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T (1992) Allele and haplotype frequencies for HLA and complement loci in various ethnic groups In: Tsuji K, Aizawa M, Sasazuki T (eds) HLA 1991. Oxford University Press, Oxford, pp 1065-1220
27. Briggs DC, Vaughan RW, Welsh KI, Myers A, duBois RM, Black CM (1991) Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet 338:661-662
28. Fanning GC, Welsh KI, Bunn C, Du Bois R, Black CM (1998) HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol 37:201-207
29. Morel PA, Chang HJ, Wilson JW, Conte C, Saidman SL, Bray JD et al (1994) Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. Hum Immunol 40:101-110 Technology Technology